Baxter International Inc. announced an agreement to acquire two hemostat and sealant products from Mallinckrodt plc : Recothrom Thrombin topical...
The Medicines Company and Bristol-Myers Squibb Company announced that the companies have signed a global license and two year collaboration...
The FDA has granted Cook Medical approval to market Hemospray, in the United States. An endoscopic hemostat, Hemospray achieves hemostasis...
Baxter International Inc. announced the launch of Hemopatch Sealing Hemostat, a novel collagen-based hemostatic device, following CE mark approval in...
Background: We analyze our experience of using TachoSil® (Takeda Austria GmbH: Linz, Austria) in microneurosurgical procedures as a hemostat and also as a sealant to patch dural defects.
The Medicines Company announced the FDA has approved Raplixa (fibrin sealant) and the Ralpixa Spray device to provide adjunctive hemostasis...
Ethicon announced that the U.S. FDA has approved an expanded indication for Evarrest Fibrin Sealant Patch, which leverages biologics to...
The FDA has approved an expanded indication for Evarrest Fibrin Sealant Patch, from Ethicon, which leverages biologics to rapidly and...
Baxter International Inc. announced the publication of two new analyses of real-world data regarding the use of Floseal Hemostatic Matrix...
The FDA has approved an additional indication for Ethicon's Evarrest (fibrin sealant patch), as an adjunct to hemostasis for control...